SynthesisHuman reproduction (Oxford, England)2021

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

Anne-Lotte L F van der Kooi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.